Found: 4
Select item for more details and to access through your institution.
Adjuvant Treatment with S-1 in Patients after R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction: A Multicenter Phase I/II Feasibility Study (GMBH-STO-0114).
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 6, p. 251, doi. 10.1159/000538143
- By:
- Publication type:
- Article
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11004-z
- By:
- Publication type:
- Article
Risk stratification for invasive aspergillosis in immunocompromised patients.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1272, n. 1, p. 23, doi. 10.1111/j.1749-6632.2012.06829.x
- By:
- Publication type:
- Article
Adherence to recommendations for the use of antifungal agents in a tertiary care hospital.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2012, v. 67, n. 10, p. 2506, doi. 10.1093/jac/dks256
- By:
- Publication type:
- Article